ERC Advanced Grant · 2021
Unraveling the regulatory networks in Streptomyces that switch on antibiotic production on demand
As Nature's medicine makers, Streptomyces bacteria produce a plethora of natural products, which we harness for clinical, biotechnological and agricultural applications, including 70% of the antibiotics. Streptomycetes still have a vast reservoir of unexplored biosynthetic potential, but many biosynthetic gene clusters (BGCs) are not expressed in the laboratory. To bring the chemical dark matter to the light, we need to discover the keys to unlock the expression of cryptic BGCs. I aim to add an entirely new dimension to genome mining, namely via understanding and exploitation of the regulatory networks that control natural product biosynthesis in Actinobacteria. My team discovered the…
From the public funding record at EU CORDIS. Describes the funded project, not the reviews below.